Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prurigo”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableStudy completedNCT04193670
What this trial is testing

Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University Hospital, Toulouse 18
Large-scale testing (Phase 3)Study completedNCT02174432
What this trial is testing

Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis

Who this might be right for
Prurigo NodularisNodularis PrurigoPrurigo
Trevi Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT05061693
What this trial is testing

Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Incyte Corporation 146
Early research (Phase 1)Study completedNCT04944862
What this trial is testing

CDX-0159 in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Celldex Therapeutics 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06527404
What this trial is testing

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Amgen 469
Large-scale testing (Phase 3)Study completedNCT04501679
What this trial is testing

Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 274
Testing effectiveness (Phase 2)WithdrawnNCT05528913
What this trial is testing

Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)

Who this might be right for
Chronic Prurigo
Charite University, Berlin, Germany
Large-scale testing (Phase 3)Looking for participantsNCT06293053
What this trial is testing

Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Sanofi 18
Not applicableUnknownNCT00532519
What this trial is testing

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Hadassah Medical Organization
Testing effectiveness (Phase 2)UnknownNCT03576287
What this trial is testing

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Tanja Todberg, MD 15
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Testing effectiveness (Phase 2)Study completedNCT00507832
What this trial is testing

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

Who this might be right for
Prurigo Nodularis
University Hospital Muenster 30
Testing effectiveness (Phase 2)Study completedNCT03181503
What this trial is testing

Safety and Efficacy of Nemolizumab in PN

Who this might be right for
Prurigo Nodularis
Galderma R&D 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06516965
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 346
Not applicableLooking for participantsNCT05316805
What this trial is testing

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

Who this might be right for
Atopic Dermatitis EczemaPrurigo Nodularis
Peking University First Hospital 100,000
Not applicableLooking for participantsNCT07276425
What this trial is testing

Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
UMC Utrecht 40
Large-scale testing (Phase 3)Looking for participantsNCT06554509
What this trial is testing

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Guangdong Hengrui Pharmaceutical Co., Ltd 423
Not applicableUnknownNCT04681300
What this trial is testing

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Who this might be right for
Prurigo NodularisAtopic Dermatitis
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Study completedNCT05755438
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo
Incyte Corporation 204
Not applicableLooking for participantsNCT05928169
What this trial is testing

Determinants of Chronic Inflammatory Skin Disease Trajectories

Who this might be right for
Atopic DermatitisPsoriasisLichen Planus+5 more
University Hospital Schleswig-Holstein 1,000
Load More Results